One scenario I keep thinking about is how far the canabidiol based suite of drugs has progressed while the spotlight has been on Sofdra. The science was already done with Sofdra and the remainder has been mainly administrative and studies performed by third party contractors. What have our white coats been up to? There has been a good 12 months of news free releases in this regard. I know they aren't on holiday - the reported expenditure is still visible. What I am hoping is a tranche of releases after the initial Sofdra hype dies down post FDA approval. I refuse to believe there has been no development on any of these drugs albeit in the background.
Bot Chart, page-11950
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $448.9M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 28.0¢ | $1.405M | 4.899M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 200490 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 345394 | 4 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
28.3¢ |
Change
-0.005 ( 3.68 %) |
||||
| Open | High | Low | Volume | ||
| 29.5¢ | 29.5¢ | 28.0¢ | 2039177 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| BOT (ASX) Chart |